Dr Amit Patel

Innovative Minimally Invasive Therapies for 🫀🫁. Biologics-immunotherapy - cells, 🧬 exosomes, powder

[Eduardo Marban, MD, PhD @MarbanLab]

Prof Keichi Fukuda of Heartseed presented optimistic 1 year clinical trial results on 4 HF patients injected surgically with allogeneic #iPS derived #cardiomyocyte #spheroids at #CABG.

[Dr Amit Patel @DoctorAmitPatel]

@elonmusk @neuralink @CMTH_Inc can help augment @neuralink for chronic back pain. Currently in FDA trials

[Dr Amit Patel @DoctorAmitPatel]

@DrTejasPatel1 @SCAI @samirpancholy Congratulations 🎊

[Dr Amit Patel @DoctorAmitPatel]

@DrTejasPatel1 Congratulations 🎉

[EACTS @EACTS]

📣 A new video has been published on MMCTS

📽️ Thoracoscopic (Non-Robotic) Harvesting of Bilateral Internal Mammary Artery Grafts

👇
https://t.co/pszqjc4TzR

[Dr Amit Patel @DoctorAmitPatel]

@medanta Congratulations 🎉

[Dr Amit Patel @DoctorAmitPatel]

@KrystalBiotech Congratulations Suma & Krish 👍🏼 Phenomenal teamwork and leadership 🙏🏼 Truly putting patients first 💯

[Joseph Coselli, MD @JCoselli_MD]

Endovascular exclusion of ascending aortic pseudoaneurysm with an experimental ascending aortic stent-graft https://t.co/Dn6WdCPgM6

[Grayson Wheatley MD @DrWheatley]

1/ Economic Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis and Low Surgical Risk: Results from the PARTNER 3 Trial 🧵

https://t.co/9klxKy9pGr

[Shalini Vinod @shalinivinod13]

1/3 people in National #lungcancer screening trial had significant incidental finding.
👉🏽 Emphysema 43%
👉🏽Coronary a Ca 12%
👉🏽Masses 7%
Need standard reporting & Mx guidelines https://t.co/vb5LQvji6n @JAMAInternalMed @JAMANetwork @nicole_rankin8n @CancerAustralia

[MyLungCancerTeam @MyLungCancer]

Perhaps you have gotten so accustomed to being blue or stressed that you assumed this was just a way of life now. But recognizing when you may actually have a condition that requires a professional evaluation is important. Read more:https://t.co/40cONay327

[Medscape Education @MedscapeCME]

📍 Do you know how to personalize care for lung cancer patients with EGFR exon 20 mutations? #Cancer #MedEd #MedTwitter #CME
📝 https://t.co/lrcg2Kb5E3

[Faisal Bakaeen MD @FaisalBakaeen]

Beautiful words from the Father of CABG. #Dr.ReneFavaloro and #Dr.MasonSones teamed together and revolutionized the care of patients with CAD. Role models for all of us.⁦@ClevelandClinic⁩ ⁦@CleClinicHVTI⁩ ⁦@CCF_CTSRes⁩

[Gregg Fonarow MD @gcfmd]

In first 100 days post 🏨 discharge for HFrEF:

One in five ☠️
Half with one or more re-🏨

Why???
Failure of optimal GDMT to work?
Failure of optimal implementation of GDMT?
Residual risk with optimal GDMT?

[S Chris Malaisrie @ChrisMalaisrie]

Minimally Invasive Mitral Valve Repair and UK Mini-Mitral Trial: How Does This Change Clinical Practice? - American College of Cardiology https://t.co/rlLTB1uUvX

[Kardioklick @kardioklick]

How is it that sometimes one vessel (here: Cx) seems totally destroyed by CAD while others (RIM, LAD) only have mild disease? Smoking, lipids etc should affect all vessels the same way, right? Anybody understand the underlying pathological process?

[Shon Chakrabarti MD MPH @shonmd]

NOW at #ACC2023

#FLAME high-risk #PE registry results

🔥@InariMedical FT pts w 1.9% in-hospital mortality
🔥Context arm consistent w hx data 29.5% in-hospital mortality
🔥Trial stopped early due 2 overwhelmingly meeting pre-defined PGs @ interim

Unheard of. Practice changing

[Dr Amit Patel @DoctorAmitPatel]

@UnivSurg @TomVargheseJr Congratulations 🎊

[Dr Amit Patel @DoctorAmitPatel]

@georgetolisjr Great Commando 💥🦄🙏🏼

[Mesenchymal Cell News @MesenchymalCell]

New in @StemCellsTM: Polish researchers have shown that umbilical cord-derived mesenchymal stem cell therapy may be a therapeutic option for patients with #MuscularDystrophy.

Read the paper: https://t.co/a7SfkQdHW7